References

  1. Coindre JM, Emile JF, Monges G, Ranchère-Vince D, Scoazec JY. Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy. Ann Pathol. 2005 Oct; 25(5):358-85. PubMed | Google Scholar

  2. Martí Obiol R, Garcés Albir M, López Mozos F, Ortega Serrano J. Surgical treatment of gastrointestinal stromal tumours. Analysis of our experience. Cir Esp 2013 Jan; 91(1):38-43. PubMed | Google Scholar

  3. Artigas Raventós V, López Pousa A, Ortega Medina L, de Liaño Argüelles AD, Fernández Hernández JA, Lucena de la Poza JL. Primary, Non-metastatic Gastrointestinal Stromal Tumor Surgery: Results of the GRISK Study. Cir Esp. 2013 Feb;91(2):96-6102. PubMed | Google Scholar

  4. Serraj I, Amrani L, Atitar I, Kanouni N, Al Baroudi S, Amrani N. Obscure gastrointestinal bleeding due to jejunal stromal tumor: the contribution of capsule endoscopy. Gastroenterol Clin Biol. 2008 Dec;32(12):1022-4. PubMed | Google Scholar

  5. Winer JH, Raut CP. Management of recurrent gastrointestinal stromal tumors. J Surg Oncol. 2011 Dec;104(8):915-20. PubMed | Google Scholar

  6. Goukassian ID, Kussman SR, Toribio Y, Rosen JE. Secondary recurrent multiple EGIST of the mesentery : A case report and review of the literature. Int Surg Case Rep. 2012;3(9):463-6. PubMed | Google Scholar

  7. Reith JD, Goldblum JR, Lyles RH, Weiss SW. Extragastrointestinal (soft tissue) stromal tumors: An analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 2000 May;13(5):577-85. PubMed | Google Scholar

  8. Kim JH, Boo YJ, Jung CW, Park SS, Kim SJ, Mok YJ, et al. Multiple malignant extragastrointestnal stromal tumors of the greater omentum and results of immunohistochemistry and mutation analysis : A case report. World J Gasrtoenterol. 2007 June; 13(24):3392-5. PubMed | Google Scholar

  9. West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004 Jul ;165(1):107-13. PubMed | Google Scholar

  10. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumor : Recent advances in understanding of their biology. Hum Pathol. 1999 Oct ;30(10):1213-20. PubMed | Google Scholar

  11. Tervahartiala P, Halavaara J. Radiology of GIST. Ann Chir Gynaecol. 1998;87(4):291-2. PubMed | Google Scholar

  12. Ortiz-Rey JA, Fernandez GC, Magdalena CJ, Alvarez C, Anton I, San Miguel P, et al. Fine Needle aspiration appareance of extragastrointestinal stromal tumor: A case report. Acta Cytol. 2003 May-Jun ;47(3):490-4. PubMed | Google Scholar

  13. Yamamoto H, Oda Y, Kawaguchi Kl, Nakamura N, Takahira T, Tamiya S, et al. C-Kit and PDGFRA mutations in extragastrointestinal stromal tumor. Am J Surg Pathol. 2004 Apr;28(4):479-88. PubMed | Google Scholar

  14. Blay JY, Le Cesne A, Ray Coquard I, Bui B, Duffaud F, Delbaldo C, et al. Prospective multicentric randomosed phase III study of Imatinib in patients with advanced gastrointestinal stromal tumor comparing interruption versus continuation of treatment beyon 1 year: The French Sarcoma Group. J Clin Oncol. 2007 Mar ;25(9):1107-13. PubMed | Google Scholar

  15. Successful treatment with sunitinib in a young patient with metastatic gastrointestinal stromal tumor after failure on adjuvant imatinib. J Can Res Ther. 2011 Oct-Dec;7(4):491-3. Google Scholar